Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma

Fig. 5

Immunofluorescence staining of U87, U251 and HeLa cells using N-methyl-D-aspartate receptor (NMDAR) subunit GLUN1 antibodies as well as α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) subunit GLUA1 antibodies (flouresceine green coloured) merged with 4′,6-diamidino-2-phenylindole (DAPI) for nuclear staining (blue coloured). As all cell lines showed staining of GluN1 and GluA1, we consider this as an indication for the presence of NMDAR and AMPAR

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us